¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Comtrex Allergy Sinus Maximum Strength"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • maximum acceptable daily intake
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®
  • maximum allowable concentration
    ÃÖ´ëÇã¿ë³óµµ
  • maximum allowable dose
    ÃÖ´ëÇã¿ë·®
  • maximum allowable limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum allowable value
    ÃÖ´ëÇã¿ëÄ¡
  • maximum breathing capacity
    ÃÖ´ëÈ£Èí¿ë·®
  • maximum cardiac output
    ÃÖ´ë½ÉÀå¹ÚÃâ·®
  • maximum compliance
    ÃÖ´ë¼øÀÀµµ
  • maximum dose
    1. ÃÖ´ë¿ë·® 2. ÃÖ´ë¼±·®
  • maximum expiratory flow rate
    ÃÖ°í³¯¼ûÀ¯¼Ó, ÃÖ°íÈ£±âÀ¯¼Ó
  • maximum flow rate
    1. ÃÖ°íÀ¯¼Ó 2. ÃÖ°íÈ帧¼Óµµ 3. ÃÖ´ëÀ¯·®
  • maximum heart rate
    ÃÖ´ë½ÉÀå¹Úµ¿¼ö, ÃÖ´ë½É¹Ú¼ö
  • maximum intensity projection
    ÃÖ´ë°­µµÅõ»ç
  • maximum midexpiratory flow
    ÃÖ´ëÁß°£³¯¼ûÀ¯·®, ÃÖ´ëÁß°£È£±âÀ¯·®
  • maximum oxygen debt
    ÃÖ´ë»ê¼ÒºÎä
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • tensile strength
    ´ç±èÈû, ½ÅÀå°­µµ
  • tinting strength
    Âø»öÈû, Âø»ö·Â
  • ultimate strength
    ±ØÇѼ¼±â, ±ØÇѰ­µµ
  • wet strength
    ½ÀÀ±µµ
  • wound strength
    â»óÈû
  • yield strength
    Ç׺¹¼¼±â
  • maximum absorption
    ÃÖ´ëÈí¼ö
  • maximum compliance
    ÃÖ´ë¼øÀÀµµ
  • maximum allowable concentration
    ÃÖ´ëÇã¿ë³óµµ
  • maximum permissible concentration
    ÃÖ´ëÇã¿ë³óµµ
  • maximum urea clearance
    ÃÖ°í¿ä¼Òû¼Ò, ÃÖ°í¿ä¼Òû¼ÒÀ²
  • maximum dose
    ÃÖ´ë¿ë·®, ÃÖ´ë¼±·®
  • maximum allowable dose
    ÃÖ´ëÇã¿ë·®
  • maximum oxygen debt
    ÃÖ´ë»ê¼ÒºÎä·®
  • maximum tolerance dose
    ÃÖ´ë³»¾à¿ë·®, ÃÖ´ë³»¾à·®, ÃÖ´ë°ßµõ¼±·®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • induced allergy
    À¯¹ß(¼º)¾Ë·¹¸£±â.
  • induced allergy
    À¯¹ß(¼º)¾Ë·¹¸£±â
  • infection allergy
    °¨¿°(Êïæø)¾Ë·¹¸£±â.
  • physical allergy
    ¹°¸®Àû ¾Ë·¹¸£±â(Úª×âîÜ¡­)
  • physical allergy
    ¹°¸®Àû ¾Ë·¹¸£±â.
  • pollen allergy
    Áµa·ç<È­ºÐ>¾Ë·¹¸£±â.
  • Lactiferous sinus
    À¯ÁóºÐºñµ¿(êáñðÝÂÝôÔ×)
  • REM-sleep-related sinus arrest
    ·½¼ö¸é °ü·Ã ½ÉÀ嵿°áÀý(Ô×Ì¿ï½) Á¤Áö
  • anal sinus
    Ç×¹®µ¿±¼
  • anterior sinus group
    ÀüºÎºñµ¿±º
  • aortic sinus
    ´ëµ¿¸Æµ¿±¼
  • aortic sinus aneurysm
    ´ëµ¿¸Æµ¿µ¿¸Æ·ù(ÓÞÔÑØæ÷ÓÔÑØæ×»).
  • aortic sinus baro(re)ceptor
    ´ëµ¿¸Æµ¿¾Ð¼ö¿ëü
  • aortic sinus fistula
    ´ëµ¿¸Æµ¿·ç.
  • aperture of frontal sinus
    À̸¶»Àµ¿±¼±¸¸Û
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • wet strength
    ½ÀÀ±µµ(ã¥ëÈöô), ½À°­µµ (ã¥Ë­öô).
  • wound strength
    â»ó°­µµ, â»ó¼¼±â, â»óÈû
  • yield strength
    Ç׺¹°­µµ(ú¢ÜÑË­öô).
  • abdominal allergy =gastrointestinal a.
    ¼ÒÈ­¼º(á¼ûùàõ) ¾Ë·¹¸£±â.
  • adhesive plaster allergy
    ¹Ýâ°í ¾Ë·¹¸£±â.
  • alimentary allergy
    ½Ä»ç¼º ¾Ë·¹¸£±â.
  • allergy
    ¾Ë·¯Áö
  • allergy
    ¾Ë·¹¸£±â.
  • allergy
    ¾Ë·¹¸£±â, °ú¹Î¹ÝÀÀ
  • allergy test
    ¾Ë·¹¸£±â½ÃÇè.
  • allergy, atopy
    ¾Ë·¹¸£±â, ¾ÆÅäÇÇ
  • allergy, contact
    Á¢Ã˼º ¾Ë·¹¸£±â
  • allergy, drug
    ¾à¹°¾Ë·¹¸£±â
  • allergy, food
    ½Äǰ¾Ë·¹¸£±â
  • allergy, fungal
    °õÆÎÀÌ ¾Ë·¹¸£±â
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Coronary sinus (partial)
    ½ÉÀåÁ¤¸Æµ¿±¼(ºÎºÐ)
    [¿¾ ¿ë¾î] °ü»óÁ¤¸Æµ¿
  • Orifice of coronary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼±¸¸Û
    [¿¾ ¿ë¾î] ½ÉÀåÁ¤¸Æµ¿±¸
  • Valve of conary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼ÆÇ¸·
    [¿¾ ¿ë¾î] °ü»óÁ¤¸Æµ¿ÆÇ
  • Valve of coronary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼ÆÇ¸·
    [¿¾ ¿ë¾î] °ü»óÁ¤¸ÆÆÇ
  • Inferior petrosal sinus
    ¾Æ·¡¹ÙÀ§Á¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] ÇÏÃßüÁ¤¸Æµ¿
  • Groove for inferior petrosal sinus
    ¾Æ·¡¹ÙÀ§Á¤¸Æµ¿±¼°í¶û
    [¿¾ ¿ë¾î] ÇÏÃßüµ¿±¸
  • Inferior sagittal sinus
    ¾Æ·¡½Ã»óÁ¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] ÇϽûóÁ¤¸Æµ¿
  • Definitive urogenital sinus
    ¿Ï¼ººñ´¢»ý½Äµ¿±¼
    [¿¾ ¿ë¾î] ¿Ï¼º¿ä»ý½Äµ¿
  • Primitive urogenital sinus
    ¿ø½Ãºñ´¢»ý½Äµ¿±¼
    [¿¾ ¿ë¾î] ¿ø½Ã¿ä»ý½Äµ¿
  • Superior petrosal sinus
    À§¹ÙÀ§Á¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] »óÃßüÁ¤¸Æµ¿
  • Groove for superior petrosal sinus
    À§¹ÙÀ§Á¤¸Æµ¿±¼°í¶û
    [¿¾ ¿ë¾î] »óÃßüµ¿±¸
  • Superior sagittal sinus
    À§½Ã»óÁ¤¸Æµ¿±¼
    [¿¾ ¿ë¾î] »ó½Ã»óÁ¤¸Æµ¿
  • Groove for superior sagittal sinus
    À§½Ã»óÁ¤¸Æµ¿±¼°í¶û
    [¿¾ ¿ë¾î] »ó½Ã»óµ¿±¸
  • Maxillary sinus branches
    À§Åε¿±¼°¡Áö
    [¿¾ ¿ë¾î] »ó¾Çµ¿Áö
  • Maxillary sinus
    À§ÅλÀµ¿±¼
    [¿¾ ¿ë¾î] »ó¾Çµ¿
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • superior petrosal sinus
    À§¾Ï¼®Á¤¸Æµ¿, »óÃßüÁ¤¸Æµ¿
  • superior sagittal sinus
    À§½Ã»óÁ¤¸Æµ¿, »ó½Ã»óÁ¤¸Æµ¿
  • umbilical sinus
    ¹è²Åµ¿, Á¦µ¿
  • urachal sinus
    ´¢¸·°üµ¿
  • urogenital sinus
    ºñ´¢»ý½Äµ¿, ¿ä»ý½Äµ¿
  • venous sinus
    Á¤¸Æµ¿
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ST esotropia; scala tympani; scaphotrapezoid; sclerotherapy; sedimentation time; semitendinosus; sensor...
Dmax maximum denaturation; maximum diameter
MAC MacConkey [broth]; major ambulatory category; malignancy-associated changes; maximum allowable conce...
MCP maximum closure pressure; maximum contraction pattern; malanocortin receptor; melphalan, cyclophosph...
MDP manic-depressive psychosis; maximum diastolic potential; maximum digital pulse; methylene diphosphat...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
LISS Low ionic strength solutions
RMS Respiratory muscle strength
SBS Shear bond strength
ST Strength training
TBS Tensile Bond Strength
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • tearing strength
    Àο­µµ
  • ultimate strength
    ±ØÇÑ °­µµ, ÃÖÁ¾ °­µµ, ÃÖ°­µµ
    1. ÀÀ·Â-º¯Çü·ü °î¼±¿¡¼­ ³ªÅ¸³ª´Â ÃÖ´ë°­µµ. 2. ÀÀ·Â-º¯ÇüÀ² ±×¸²»óÀÇ ¿Ü°ü»ó ÃÖ´ë ÀÀ·Â. ÇÏÁßÀÇ Á¾·ù¿¡ µû¶ó ÀÎÀå °­µµ, ¾ÐÃà °­µµ, Àü´Ü °­µµ µîÀ¸·Î ±¸º°µÈ´Ù.
  • wet strength
    ½ÀÀ±µµ, ½À°­µµ
    ¹Ý¼öÈ­¹°¿¡ ÇÊ¿äÇÑ ¼öÈ­ Á¤µµ ÀÌ»óÀ¸·Î °úÇÏ°Ô ¼öºÐÀÌ Á¸ÀçÇÏ´Â ½ÃÆí¿¡ À־ÀÇ °­µµ. ¼®°í ÁÖÀÔ ÈÄ 1½Ã°£ °æ°ú ÈÄÀÇ °­µµ¸¦ ¶æÇÑ´Ù. dry strengthº¸´Ù 2¹è °­µµ°¡ ¶³¾îÁø´Ù.
  • absorption maximum
    ÃÖ´ë Èí¼ö
  • maximum
    ÃÖ´ë, ÃÖ°í, ±ØÄ¡
    1. °¡Àå °¡´É¼ºÀÌ Àִ ȤÀº ½ÇÁ¦ÀÇ °á°ú ȤÀº ¼ö·®. 2. º´À̳ª °úÁ¤ÀÇ °íºñ, ÀýÁ¤.
  • maximum accumulation dose
    ÃÖ´ë ÃàÀû·®
  • maximum allowable concentration
    ÃÖ´ë Çã¿ë ³óµµ
  • maximum allowable limit
    ÃÖ´ë Çã¿ë ÇѰè
  • maximum and minimum thermometer
    ÃÖ°í ÃÖÀú ¿Âµµ°è
  • maximum comfortable opening
    ÃÖ´ë ¹«Å뼺 °³±¸
  • maximum discrimination score
    ÃÖ´ë ¸í·áÄ¡
  • maximum expiratory flow rate
    ÃÖ´ë È£±â À¯·®·ü
  • maximum foundation plane
    ÀÇÄ¡»ó Æò±Õ Àú¸é
  • maximum intercuspal contact
    ÃÖ´ë ±³ÇÕ Á¢ÃË
  • maximum intercuspation
    ÃÖ´ë ±³µÎ°£À§, ÃÖ´ë ±³µÎ °¨ÇÕ, ÃÖ´ë ±³ÇÕ
    »ó, ÇÏ¾Ç Ä¡¾ÆÀÇ ±³µÎµéÀÌ °¡Àå ¸¹ÀÌ Á¢ÃËÇÏ´Â °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
cold allergy Physical symptoms produced by hypersensitivity to cold.
(05 Mar 2000)
contact allergy A delayed type IV allergic reaction of the skin with varying degrees of erythema, oedema, and vesiculation resulting from cutaneous contact with a specific allergen.
Synonym: contact allergy.
(05 Mar 2000)
polyvalent allergy Allergic response manifested simultaneously for several or numerous specific allergens.
(05 Mar 2000)
shots, allergy Known medically as allergy desensitization or allergy immunotherapy, the injections are designed to stimulate the immune system with gradually increasing doses of the substances to which a person is allergic, the aim being to modify or stop the allergy war (by reducing its effect on the mast cells). This form ofhe strength of the IgE and its treatment is very effective for allergies to pollen, mites, cats, and especially stinging insects (e.g., bees, hornets, yellowjackets, wasps, velvet ants, fire ants). Allergy immunotherapy usually takes 6 months to a year to become effective and injections are usually required for 3-5 years.
(12 Dec 1998)
skin test for allergy Test done on the skin to identify the allergy substance (allergen) triggering the allergic reaction. A small amount of the suspected allergy substance is placed on the skin. The skin is then gently scratched through the small drop with a special sterile needle. If the skin reddens and, more importantly, swells, then allergy to that substance is probable.
(12 Dec 1998)
delayed allergy A type IV allergic reaction; so called because in a sensitised subject the reaction becomes evident hours after contact with the allergen (antigen), reaches its peak after 36 to 48 hours, then recedes slowly. Associated with cell-mediated responses.
See: delayed reaction.
Compare: immediate allergy.
(05 Mar 2000)
desensitization, allergy Stimulation of the immune system with gradually increasing doses of the substances to which a person is allergic, the aim being to modify or stop the allergy war (by reducing the strength of the IgE and its effect on the mast cells). This form of treatment is very effective for allergies to pollen, mites, cats, and especially stinging insects (e.g., bees, hornets, yellowjackets, wasps, velvet ants, fire ants). Allergy immunotherapy usually takes 6 months to a year to become effective and shots (injections) are usually required for 3-5 years.
(12 Dec 1998)
drug allergy Sensitivity (hypersensitivity) to a drug or other chemical.
(05 Mar 2000)
immediate allergy A type I allergic reaction; so called because in a sensitised subject the reaction becomes evident usually within minutes after contact with the allergen (antigen), reaches its peak within an hour or so, then rapidly recedes.
See: immediate reaction, anaphylaxis.
Compare: delayed allergy.
(05 Mar 2000)
immunotherapy, allergy Stimulation of the immune system with gradually increasing doses of the substances to which a person is allergic, the aim being to modify or stop the allergy war (by reducing the strength of the IgE and its effect on the mast cells). This form of treatment is very effective for allergies to pollen, mites, cats, and especially stinging insects (e.g., bees, hornets, yellow jackets, wasps, velvet ants, fire ants). Allergy immunotherapy usually takes 6 months to a year to become effective and shots (injections) are usually required for 3-5 years.
(12 Dec 1998)
insulin allergy When a person's body has an allergic or bad reaction to taking insulin made from pork or beef or from bacteria, or because the insulin is not exactly the same as human insulin or because it has impurities. The allergy can be of two forms. Sometimes an area of skin becomes red and itchy around the place where the insulin is injected. This is called a local allergy. In another form, a person's whole body can have a bad reaction. This is called a systemic allergy. The person can have hives or red patches all over the body or may feel changes in the heart rate and in the rate of breathing. A doctor may treat this allergy by prescribing purified insulins or by desensitisation.
See: desensitisation.
(09 Oct 1997)
test, skin, for allergy A test done on the skin to identify the allergy substance (allergen) triggering the allergic reaction. A small amount of the suspected allergy substance is placed on the skin. The skin is then gently scratched through the small drop with a special sterile needle. If the skin reddens and, more importantly, swells, then allergy to that substance is probable.
(12 Dec 1998)
latent allergy Allergy that causes no signs or symptoms but can be revealed by means of certain immunologic tests with specific allergens.
(05 Mar 2000)
Amberg's lateral sinus line A line dividing the angle formed by the anterior edge of the mastoid process and the temporal line.
(05 Mar 2000)
aneurysm of sinus of Valsalva A congenital thin-walled tubular out pouching usually in the right or non-coronary sinus with an entirely intracardiac course that may rupture into the right or rarely the left heart chambers to form an aortocardiac fistula.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á